At Davos 2026, Novartis CEO Vas Narasimhan said regulatory clarity in the US and a rapid reshaping of the company’s supply ...

While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

Novartis CEO Vas Narasimhan told CNBC on Tuesday he expects the drugmaker's agreement with the U.S. government and its ...

Crocs, LIV Golf, Netflix and Warner Bros also feature among nine bite-sized news updates. Both the UK and EU registers saw a ...

Novartis has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ...

Novartis has published an open letter to governments around the world, and particularly the EU, Canada, and Japan, urging ...

Aman Mehta, Managing Director of Torrent Pharma, has been appointed Managing Director of JB Pharma for a three‑year term.

Designation based on clinical evidence supporting potential of ianalumab in Sjögren's disease, including phase III trials1Distinction expedites development and review of treatments for serious conditi ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual ...

AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...

Designation based on clinical evidence supporting potential of ianalumab in Sjögren’s disease, including phase III trials1Distinction expedites development and review of treatments for serious ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...